EBR Systems, Inc. is a biotechnology company founded in 2003 and headquartered in the United States. The company is focused on revolutionizing treatment for cardiac rhythm diseases through the development of wireless cardiac stimulation technologies. Their flagship product, the WiSE® CRT System, aims to address the limitations of traditional Cardiac Resynchronization Therapy (CRT) by eliminating the need for a lead to the heart’s left ventricle, thus reducing associated complications. EBR Systems, Inc.'s commitment is reflected in its recent $30.00M Private Equity Round investment, which was secured on 27 August 2019. The investment was contributed by notable firms including Ascension Ventures, Emergent Medical Partners, Split Rock Partners, M. H. Carnegie, and Brandon Capital. It's important to note that the WiSE® CRT System is currently an investigational device, limited by US Law to investigational use only.
EBR Systems, Inc.
Overcoming the limitations of conventional CRT through Wireless, LV Endocardial Pacing
Sunnyvale, United States
89 employees
Private Equity
Total: $199.86M
Biotechnology, Health Care +1
General Information
Sunnyvale, United States
BounceWatch is an independent company data service, not affiliated with EBR Systems, Inc.. To contact EBR Systems, Inc., visit ebrsystemsinc.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does EBR Systems, Inc. compare?
A PDF of EBR Systems, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting EBR Systems, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About EBR Systems, Inc.
Business keywords: cardiac rhythm disease, wireless stimulation, LV endocardial pacing, medical device innovation, heart failure treatment, CRT therapy, clinical superiority, cost-effective therapy, reliable cardiac stimulation, left ventricle pacing, investigational device, heart failure, cardiac resynchronization therapy, innovative medical technology
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Private Equity Round | $30.00M | 5 |
|
27 Aug 2019 |
| Private Equity Round | $50.00M | 5 |
|
14 Nov 2017 |
| Venture Round | $20.00M | 6 |
|
08 Apr 2015 |
| Venture Round | $18.70M | 3 |
|
01 Jul 2014 |
| Series D | $5.00M | 4 |
|
10 Feb 2011 |
| Venture Round | $15.00M | 5 |
|
31 Dec 2009 |
| Series C | $35.00M | 5 |
|
12 Jun 2008 |
| Series B | $21.00M | 4 |
|
01 Oct 2005 |
| Series A | $5.16M | 3 |
|
01 Jun 2004 |
EBR Systems, Inc. Alternatives & Competitors
View All Alternatives
Reshaping the Course of Heart Failure®
Heart Failure is one of the most debilitating medical issues we face. It is the leading cause of hos...
A cardiac medical device company determined to improve the lives of heart failure patients through C...
FAQ About EBR Systems, Inc.
Source: BounceWatch company record for EBR Systems, Inc., https://bouncewatch.com/company/ebr-systems-inc, updated 25 November 2024. When citing, please name BounceWatch and link this page.
